The Modeled Lifetime Cost-Effectiveness of Published Adherence-Improving Interventions for Antihypertensive and Lipid-Lowering Medications
Cost-Effectiveness of Therapeutic Hypothermia to Treat Neonatal Encephalopathy
Cost-Effectiveness of the Addition of Rituximab to CHOP Chemotherapy in First-Line Treatment for Diffuse Large B-Cell Lymphoma in a Population-Based Observational Cohort in British Columbia, Canada
The Unit Costs of Inpatient Hospital Days, Outpatient Visits, and Daycare Treatments in the Fields of Oncology and Hematology
Evaluating Willingness-to-Pay Thresholds for Dementia Caregiving Interventions: Application to the Tailored Activity Program
Projected Cost-Effectiveness of Ezetimibe/Simvastatin Compared with Doubling the Statin Dose in the United Kingdom: Findings from the INFORCE Study
The Cost-Effectiveness of Spinal Cord Stimulation for Complex Regional Pain Syndrome
Willingness to Pay for Lung Cancer Treatment
Modeling the Long-Term Cost-Effectiveness of the Caries Management System in an Australian Population
An Ounce of Prevention Is Worth a Pound of Cure: A Cost-Effectiveness Analysis of Incidentally Detected Aneurysms in Functional MRI Research
A Multimarker Approach for the Prediction of Coronary Artery Disease: Cost-Effectiveness Analysis
Differences in Child versus Parent Reports of the Child' Health-Related Quality of Life in Children with Epilepsy and Healthy Siblings
Clustering Rasch Results: A Novel Method for Developing Rheumatoid Arthritis States for Use in Valuation Studies
A Competing Risks Prescription Refill Model of Compliance and Persistence
Adherence, Discontinuation, and Switching of Biologic Therapies in Medicaid Enrollees with Rheumatoid Arthritis
Measuring Patient Anxiety in Primary Care: Rasch Analysis of the 6-item Spielberger State Anxiety Scale
Persistence Patterns with Oral Antidiabetes Drug Treatment in Newly Treated Patients—A Population-Based Study
Medical Services Utilization and Expenditure of Obesity-Related Disorders in Taiwanese Adults
How Do Cost-Effectiveness Analyses Inform Reimbursement Decisions for Oncology Medicines in Canada? The Example of Sunitinib for First-Line Treatment of Metastatic Renal Cell Carcinoma
The Impact of Value-Based Benefit Design on Adherence to Diabetes Medications: A Propensity Score-Weighted Difference in Difference Evaluation
Quantification of the Potential Impact of Cost-effectiveness Thresholds on Dutch Drug Expenditures Using Retrospective Analysis
Health Technology Assessment and Economic Evaluation across Jurisdictions
Health Technology Assessment and Economic Evaluation: Arguments for a National Approach